SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
antiplatelet
Journals
4
1
Life (Basel, Switzerland)
2
Thrombosis research
3
World journal of urology
4
pharmaceutical medicine
Research Groups
0
No Research Group Connected
Bibliographies
33
1
Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines.
2
Evaluation of the Implementation of Additional Risk Minimization Activities in Europe, the USA, and Japan.
3
management of antithrombotic therapy during cardiac implantable device surgery
4
WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor.
5
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review.
6
Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study.
7
Economic evaluation of the use of non-Vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: A modelling analysis using the healthcare system in the Netherlands
8
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
9
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
10
Does the timing of aspirin administration influence its antiplatelet effect - review of literature on chronotherapy.
11
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
12
Ultrasound-guided bilateral combined inguinal femoral and subgluteal sciatic nerve blocks for simultaneous bilateral below-knee amputations due to bilateral diabetic foot gangrene unresponsive to peripheral arterial angioplasty and bypass surgery in a coagulopathic patient on antiplatelet therapy with a history of percutaneous coronary intervention for ischemic heart disease: A case report
13
Antiplatelet therapy and anticoagulation in patients with hypertension.
14
Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
15
Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.
16
The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.
17
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
18
Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
19
change of platelet reactivity to antiplatelet therapy after stenting procedure for cerebral artery stenosis: verifynow antiplatelet assay before and after stenting
20
optimizing antiplatelet / antithrombotic therapy
21
role of sodium tungstate as a potential antiplatelet agent
22
dual antiplatelet therapy (dapt) in post-pci patients beyond one year
23
the study of price situation on the domestic antiplatelet market
24
antiplatelet aggregation activity of walnut hull extract via suppression of reactive oxygen species generation and caspase activation
25
anti-inflammatory and antiplatelet activities of plasma are conserved across twelve mammalian species
26
antiplatelet therapy control: credibility gap or search for new decisions?
27
the impact of antiplatelet therapy on pelvic fracture outcomes
28
antiplatelet, antithrombotic, and fibrinolytic activities of campomanesia xanthocarpa
29
risk of bleeding in patients undergoing percutaneous endoscopic gastrotrostomy tube insertion under antiplatelet therapy
30
antiplatelet drugs resistance in patients with ischemic heart disease and obliterative atherosclerosis of lower limb arteries associated with diabetes mellitus type 2
31
the personalization of clopidogrel antiplatelet therapy: the role of integrative pharmacogenetics and pharmacometabolomics
32
Prior Use of Antiplatelet Therapy and Outcomes after Endovascular Therapy in Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single-Center Experience
33
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.